May 6, 2013 | Cancer drugs are expensive to make and expensive for patients. Last week 100 cancer specialists published an op ed in Blood claiming that the high cost of drugs is preventing some patients from being treated. But there is a win-win solution, and discounting drugs could give pharma companies big profits. Harvard Business Review